Monday, 28 April 2014
INDIAN EQUITY BENCHMARKS ended lower,
amid a range bound trading session, tracking weakness among Asian peers while the
geo-political crisis in Ukraine also dampened market sentiment.
Further, Wock Pharma surged by 11.7%
after the regulator in Himachal Pradesh has revoked the suspension of the
manufacture and sale of three drugs. UPL has surged 20% after reporting a robust
28% year-on-year growth in adjusted consolidated net profit at Rs 405 crore for
the fourth quarter ended March 31, 2014 mainly due to higher operational income
and lower employee costs.
The crucial resistance for Nifty is now
seen at 6800 and above this 6830. Support for the immediate term
is now placed at 6700 and next
support will be 6670.
